Ledger.Open graph →
SEC Form D · filed May 15, 2018

MABVAX THERAPEUTICS HOLDINGS, INC

Offering
$860K
Sold
$830K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

J. David Hansen · San Diego, CAExec · DirectorPaul V. Maier · San Diego, CADirectorKenneth M. Cohen · San Diego, CADirectorJeffrey F. Eisenberg · San Diego, CADirectorThomas C. Varvaro · San Diego, CADirectorGregory P. Hanson · San Diego, CAExecPaul W. Resnick · San Diego, CAExecPhilip O. Livingston · San Diego, CADirectorPaul W. Maffuid · San Diego, CAExecBryen J. Salas · Tacoma, WADirectorBrian C. Lofquist · Tacoma, WADirectorChristian J. Struzan · Tacoma, WAExecJoanne C. Salas · Tacoma, WADirectorBrett A. Hickey · New York, NYDirectorJim T. Collord · Boise, IDExec · DirectorPaul Resnick · Lexington, MAExecScott M. Manson · TACOMA, WAExecAustin J. Gorst · Tacoma, WADirectorScott C. Telesz · New York, NYDirectorScott C. Stanley · New York, NYExecSalim C. Samaha · New York, NYDirectorRajaram C. Rao · New York, NYDirectorMichael C. Mcghee · New York, NYDirectorBruce C. Maclennan · New York, NYExecScott C. Hatton · New York, NYExecMatthew C. Harris · New York, NYExec · DirectorAndrew J. Gillespie-Smith · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗